Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
38.8M
-
Number of holders
-
92
-
Total shares
-
24.9M
-
Shares change
-
+176K
-
Total reported value, excl. options
-
$234M
-
Value change
-
+$136K
-
Put/Call ratio
-
1.72
-
Number of buys
-
46
-
Number of sells
-
-37
-
Price
-
$9.38
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 par value (ATHA) as of Q3 2021
92 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 par value as of Q3 2021.
Athira Pharma, Inc. - Common Stock, $0.0001 par value (ATHA) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
of 38.8M outstanding shares and own 64.13% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.43M shares), FRANKLIN RESOURCES INC (2.08M shares), BlackRock Inc. (2.01M shares), RTW INVESTMENTS, LP (1.91M shares), Logos Global Management LP (1.86M shares), VANGUARD GROUP INC (1.64M shares), VR Adviser, LLC (1.2M shares), PATHSTONE FAMILY OFFICE, LLC (1.15M shares), CITADEL ADVISORS LLC (1.14M shares), and WASATCH ADVISORS INC (896K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.